Impact of diagnostic and end-of-induction Curie scores with tandem high-dose chemotherapy and autologous transplants for metastatic high-risk neuroblastoma: A report from the Children's Oncology Group.
Keri A StrebyMarguerite T ParisiBarry L ShulkinBrian LaBarreRochelle BagatellLisa DillerStephan A GruppKatherine K MatthayStephan D VossAlice L YuWendy B LondonJulie R ParkGregory A YanikArlene NaranjoPublished in: Pediatric blood & cancer (2023)
In the setting of tandem transplantation for children with high-risk neuroblastoma, CS at diagnosis and EOI may identify a more favorable patient group. Patients treated with tandem HDC who exhibited a CS ≤ 12 at diagnosis or CS = 0 at EOI had superior EFS compared to those with CS above these cut points.